Sarcoma Archives

ONS Annual Congress 2023

First-in-Use Assessment Tool Identifies Early Onset of Neurotoxicity

By

Joyce Pagan

April 28, 2023

A nurse-led team developed a tool to assess patients with sarcoma undergoing multiday ifosfamide regimens for early signs of neurotoxicity.

Sarcoma

Case Series Describes Link Between Koebner Phenomenon and Kaposi Sarcoma

By

Vicki Moore, PhD

February 27, 2023

Researchers described possible associations between Kaposi sarcoma and Koebner phenomenon in a case series of patients with lesions appearing after a prior cutaneous injury.

Sarcoma

Intratumoral Microbiome in Soft Tissue Sarcoma Linked to Prognosis

By

Jennifer Larson

February 15, 2023

Researchers explored the possibility of an intratumoral microbiome being present in soft tissue sarcoma, similar to other cancer types.

Sarcoma

Location of KIT Mutations Impacts Response to TKIs in Patients With GIST

By

Andrea S. Blevins Primeau, PhD, MBA

February 8, 2023

The location of KIT mutations is associated with response to ripretinib and sunitinib in patients with previously treated GIST, research suggests.

Sarcoma

Tecentriq Approved for Unresectable or Metastatic Alveolar Soft Part Sarcoma

By

Brian Park, PharmD

January 9, 2023

The approval was based on data from a phase 2 study that included 49 patients with unresectable or metastatic ASPS.

Sarcoma

Shorter Regimen of Radiotherapy Safe for Soft Tissue Sarcoma

November 29, 2022

Findings with preoperative radiotherapy administered to dose of 42.75 Gy in 15 fractions for three weeks.

General Oncology

MYC Inhibitor Can Stave Off Progression in Patients With Advanced Solid Tumors

By

Andrea S. Blevins Primeau, PhD, MBA

November 9, 2022

In a first-in-human trial of patients with solid tumors, a MYC inhibitor appeared tolerable and enabled nearly half of evaluable patients to maintain stable disease.